CLINICAL_TRIALS
trial_result
· 2012-04-04
Clinical Trial Update: Repeat Dose Safety Study for Compound to Treat Hematologic Cancer [Phase 1, Phase 2]
Summary
Completed Phase 1/2 safety study evaluating a compound for hematologic malignancies, focusing on repeat-dose safety.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Accenture | Conditions: Hematologic Malignancies | Phase 1, Phase 2 | Status: COMPLETED